Quantbot Technologies LP Acquires Shares of 21,400 Ingevity Corporation $NGVT

Quantbot Technologies LP bought a new stake in Ingevity Corporation (NYSE:NGVT) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 21,400 shares of the company’s stock, valued at approximately $1,598,000.

Other institutional investors have also recently made changes to their positions in the company. Global Retirement Partners LLC purchased a new position in shares of Ingevity during the 4th quarter worth about $27,000. Meeder Asset Management Inc. purchased a new stake in Ingevity in the 4th quarter worth about $33,000. Geneos Wealth Management Inc. raised its position in Ingevity by 85.8% in the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after purchasing an additional 387 shares during the period. Frazier Financial Advisors LLC purchased a new stake in Ingevity in the 2nd quarter worth about $37,000. Finally, Headlands Technologies LLC bought a new stake in Ingevity in the second quarter worth about $46,000. Institutional investors own 91.59% of the company’s stock.

Ingevity Price Performance

Shares of NGVT stock opened at $68.88 on Tuesday. The company has a debt-to-equity ratio of 22.52, a current ratio of 1.61 and a quick ratio of 1.15. The company has a market capitalization of $2.37 billion, a P/E ratio of 46.86 and a beta of 1.16. The company’s 50-day simple moving average is $73.77 and its two-hundred day simple moving average is $71.86. Ingevity Corporation has a one year low of $45.85 and a one year high of $79.29.

Ingevity (NYSE:NGVT) last issued its earnings results on Wednesday, July 29th. The company reported $1.74 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.41. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. The business had revenue of $314.10 million for the quarter, compared to analyst estimates of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. As a group, equities analysts anticipate that Ingevity Corporation will post 5.4 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Weiss Ratings upgraded Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Friday, July 31st. Wall Street Zen downgraded Ingevity from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 1st. Two research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $80.00.

Insider Buying and Selling

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of Ingevity stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total transaction of $33,971.04. Following the completion of the sale, the senior vice president directly owned 7,202 shares of the company’s stock, valued at $493,264.98. The trade was a 6.44% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO David H. Li sold 5,000 shares of the company’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $75.83, for a total value of $379,150.00. Following the completion of the sale, the chief executive officer owned 120,636 shares of the company’s stock, valued at $9,147,827.88. This represents a 3.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 18,297 shares of company stock valued at $1,381,452 over the last quarter. 0.88% of the stock is owned by corporate insiders.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.